Full-Time

Life Sciences Experienced Analyst

Posted on 9/8/2026

ClearView Healthcare Partners

ClearView Healthcare Partners

501-1,000 employees

Life sciences strategy consulting for biopharma

No salary listed

Gurugram, Haryana, India

Hybrid

New hires work in the office full-time during onboarding and training, followed by a 50% in-office expectation.

Bachelor's, Master's

Category
Consulting (1)
Required Skills
Microsoft Office
Data Analysis
Excel/Numbers/Sheets
Microsoft Outlook
PowerPoint/Keynote/Slides

Get referred to ClearView Healthcare Partners

See people who can refer or advise you

Requirements
  • Demonstrated experience in consulting and the life sciences industry through a combination of internships, research, and workstream management.
  • Strong written and oral communication skills in English.
  • Proficient in Microsoft Office Suite, including Outlook, Excel, and PowerPoint.
  • A highly analytical and structured approach to solving complex problems.
  • An undergraduate or master's degree in life sciences or equivalent.
  • A minimum of 12 months of experience in life sciences consulting.
Responsibilities
  • Conduct complex problem-solving through a hypothesis-based approach.
  • Complete primary and secondary research to drive critical insights.
  • Create and utilize analytic tools, such as forecast models, to support key decision-making.
  • Communicate recommendations to clients to inform strategy and maximize value.
ClearView Healthcare Partners

ClearView Healthcare Partners

View

ClearView Healthcare Partners provides strategic consulting services exclusively for the life sciences sector, guiding pharmaceutical, biotechnology, medical devices, and diagnostics firms through decisions from discovery to commercialization. It completes project work with 100% of a dedicated team focused on a single client engagement, pairing rigorous scientific knowledge with business strategy, with many consultants holding life sciences PhDs. The firm differentiates itself through its strict one-client-per-project model, sector-only focus, and deep scientific expertise, plus international expansion to serve global clients. Its goal is to help life sciences companies grow, advance product development, and secure market access, creating value across the entire product lifecycle.

Company Size

501-1,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Newton, Massachusetts

Founded

2008

Get referred to ClearView Healthcare Partners

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • 2026 content on obesity, vaccines, FTC settlement, and Korea biotech signals active demand capture.
  • GHO-backed global expansion since 2021 still broadens European and Indian client reach.
  • ClearView's 2025 Epistemic AI stake can speed analysis and improve delivery economics.

What critics are saying

  • McKinsey, BCG, and ZS can undercut ClearView with broader AI-enabled service platforms.
  • Epistemic AI integration commoditizes research-heavy work, pressuring margins through 2026.
  • If clients internalize strategy with AI, ClearView's project-based model loses pricing power.

What makes ClearView Healthcare Partners unique

  • Largest independent life-science strategy consultancy, with offices across Boston, London, Zurich, and Gurgaon.
  • 2025 minority investment in Epistemic AI embeds biomedical AI into ClearView workflows.
  • PhD-heavy teams and exclusive life-sciences focus create deeper technical credibility than generalist firms.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Hybrid Work Options

Remote Work Options

Health Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Paid Holidays

Flexible Work Hours

Wellness Program

Mental Health Support

Professional Development Budget

Conference Attendance Budget

Stock Options

Company Equity

Family Planning Benefits

Fertility Treatment Support

Home Office Stipend

Phone/Internet Stipend

Parental Leave

Adoption Assistance

Meal Benefits

Relocation Assistance

Employee Referral Bonus

Tuition Reimbursement

Professional Certification Support

Mentorship Program

Training Programs

Growth & Insights and Company News

Headcount

6 month growth

12%

1 year growth

12%

2 year growth

13%
PR Newswire
Mar 12th, 2025
The Addf'S Diagnostics Accelerator Authors New Paper On Ocular Biomarker Landscape, Highlighting Ocular Tests As A Tool For Early Detection Of Alzheimer'S Disease

New findings published in Alzheimer's Dementia suggest blood biomarkers are expected to become the standard method for diagnosing Alzheimer's, while ocular tests offer a non-invasive alternative for detecting at-risk patient populations NEW YORK, March 12, 2025 /PRNewswire/ -- The Alzheimer's Drug Discovery Foundation's (ADDF) Diagnostics Accelerator (DxA) authored a first-of-its-kind paper, "Unlocking ocular biomarkers for early detection of Alzheimer's disease," providing a landscape review of ocular biomarkers as another tool, alongside blood biomarkers, to aid in the early detection of Alzheimer's disease. The paper, which was published in Alzheimer's Dementia, shares an informed perspective on the role of ocular biomarkers in the broader Alzheimer's diagnostics space and what defines a true ocular biomarker, while also highlighting the potential for ocular screening to identify at-risk patients who would otherwise go undiagnosed. The authors' assessment is based on hours of in-depth interviews with leading neurologists, ophthalmologists, optometrists, and primary care physicians from across the United States

Citybiz
Jan 13th, 2025
ClearView Healthcare Partners Invest In Epistemic AI

BOSTON, MA and WESTPORT, CT – 13 January 2025: ClearView Healthcare Partners, the leading life sciences strategic consultancy supporting Pharma... Read More

Citybiz
Jan 13th, 2025
ClearView Invests $4M in Epistemic AI

ClearView Healthcare Partners announced a $4 million minority investment in Epistemic AI to enhance its EpistemicGPT platform, which combines AI with a vast biomedical knowledge graph. This partnership aims to improve ClearView's service offerings by integrating AI technology, enhancing research and drug development processes. The collaboration underscores a commitment to advancing biomedical research and healthcare outcomes through innovative technology solutions.

Digital Therapeutics Alliance
Nov 15th, 2023
DTx Commercialization Launch Playbook Case Study

Digital Therapeutics Alliance is thrilled to announce the release of its latest white paper in collaboration with Clearview Healthcare Partners!

Foundation Fighting Blindness
Feb 13th, 2023
The Foundation's long-term impact on moving the inherited retinal disease field forward towards treatments and cures. — Foundation Fighting Blindness

The Foundation Fighting Blindness partnered with ClearView Healthcare Partners to evaluate the impact of its funding and resources since 2005 on the clinical understanding and development of novel therapies for inherited retinal diseases (IRDs).